Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Balwani

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Molecular Genetics and Metabolism Reports|February 22, 2021
The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher diseaseAshlee R Stiles, Erin Huggins, Luca Fierro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2023
Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registryManisha Balwani, William Balistreri, Lorenzo D'Antiga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2025
Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International RegistryLorenzo D'Antiga, Jennifer Evans, Emilio Ros, et al.
Molecular Genetics and Metabolism|April 16, 2018
Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patientsDonna Lee Bernstein, Steven Lobritto, Alina Iuga, et al.
American Journal of Hematology|May 22, 2020
Real-world effectiveness of eliglustat in treatment-naïve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher RegistryPramod K Mistry, Manisha Balwani, Joel Charrow, et al.
Orphanet Journal of Rare Diseases|October 3, 2024
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension studyEliane Sardh, Manisha Balwani, David C Rees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2021
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJasmin Galper, Manisha Balwani, Stanley Fahn, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 14, 2016
Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screeningAmy C Yang, Louise Bier, Jessica R Overbey, et al.
Chest|July 9, 2022
A 51-Year-Old Woman With Interstitial Lung Disease and Subsequent COVID-19 Presenting With Worsening DyspneaNicole Ng, Jigna Zatakia, Mary B Beasley, et al.
JIMD Reports|April 21, 2025
Self-Reported Liver Disease and the Burden of Erythropoietic ProtoporphyriaHetanshi Naik, Kristen Wheeden, Hilary H Colwell, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Molecular Genetics and Metabolism Reports|February 22, 2021
The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher diseaseAshlee R Stiles, Erin Huggins, Luca Fierro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2023
Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registryManisha Balwani, William Balistreri, Lorenzo D'Antiga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2025
Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International RegistryLorenzo D'Antiga, Jennifer Evans, Emilio Ros, et al.
Molecular Genetics and Metabolism|April 16, 2018
Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patientsDonna Lee Bernstein, Steven Lobritto, Alina Iuga, et al.
American Journal of Hematology|May 22, 2020
Real-world effectiveness of eliglustat in treatment-naïve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher RegistryPramod K Mistry, Manisha Balwani, Joel Charrow, et al.
Orphanet Journal of Rare Diseases|October 3, 2024
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension studyEliane Sardh, Manisha Balwani, David C Rees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2021
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJasmin Galper, Manisha Balwani, Stanley Fahn, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 14, 2016
Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screeningAmy C Yang, Louise Bier, Jessica R Overbey, et al.
Chest|July 9, 2022
A 51-Year-Old Woman With Interstitial Lung Disease and Subsequent COVID-19 Presenting With Worsening DyspneaNicole Ng, Jigna Zatakia, Mary B Beasley, et al.
JIMD Reports|April 21, 2025
Self-Reported Liver Disease and the Burden of Erythropoietic ProtoporphyriaHetanshi Naik, Kristen Wheeden, Hilary H Colwell, et al.
Pageof 10